PROBIOTIKI V PROFILAKTIKE ANTIBIOTIKO-ASSOTsIIROVANNOY DIAREI U DETEY RANNEGO VOZRASTA


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents the results of a comparative randomized clinical trial compared the effectiveness of symbiotic Normobact with probiotic Linex as part of comprehensive prevention of antibiotic-associated diarrhea in infants. The study included 60 children aged 6 to 12 months with no clinically significant pathology of the gastrointestinal tract who received antibiotics for the treatment of underlying disease. It is proved that the use of products containing probiotic bacteria cultures, can delay development of diarrheal phenomena, reduce its degree and promote more rapid relief of symptoms. The best results in terms of reducing dyspepsia were observed against the background of use of symbiotic Normobact compared with Linex, which is likely due to the presence of prebiotic (raftilose) and a higher concentration of bifidobacteria and lactobacilli in the composition of Normobact.

Full Text

Restricted Access

References

  1. Захарова И.Н. Антибиотико-ассоциированная диарея: патогенез и лечение. Лечащий врач. 2013;1:35-40.
  2. Mondot S., de Wouters T., Dore J., Lepage P. The human gut microbiome and its dysfunctions. Dig. Dis. 2013;31 (3-4):2 78-85.
  3. Duca F., G rard P., Covasa M., Lepage P. Metabolic interplay between gut bacteria and their host. Front. Horm. Res. 2014;42:73-82.
  4. Kelly D., King T., Aminov R. Importance of microbial colonization of the gut in early life to the development of immunity. Mutat. Res. 2007;622:58-69.
  5. Geuking M.B., Koller Y., Rupp S., McCoy K.D. The interplay between the gut microbiota and the immune system. Gut. Microbes. 2014;5(3):411-18.
  6. Okada H., Kuhn C., Feillet H., Bach J.F. The «hygiene hypothesis» for autoimmune and allergic diseases: an update. Clin. Exp. Immunol. 2010;160:1-9.
  7. Rook G. W. Hygiene hypothesis and autoimmune diseases. Clin. Rev. Allergy Immunol. 2012;42:5-15.
  8. L'win-Le MoalV, Servin A.L. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin. Microbiol. Rev.2006;19:315-37.
  9. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., Nalin R., Jarrin C., Chardon P., Marteau P., Roca J., Dore J. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55:205-11.
  10. Compare D., Nardone G. Contribution of gut microbiota to colonic and extracolonic cancer development. Dig. Dis. 2011;29:554-61.
  11. Bultman SJ. Emerging roles of the microbiome in cancer. Carcinogenesis. 2014;35:249-55.
  12. Aagaard K., Ma J., Antony K.M., Ganu R., Petrosino J., Versalovic J. The placenta harbors a unique microbiome. Sci. Transl. Med. 2014;6:237-65.
  13. Marques T.M., Wall R., Ross R.P., Fitzgerald G.F., Ryan C.A., Stanton C. Programming infant gut microbiota: influence of dietary and environmental factors. Curr. Opin. Biotechnol. 2010;21:149-56.
  14. Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M., Hidalgo G., Fierer N., Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA. 2010;107:11971-75.
  15. Koenig J.E., Spor A., Scalfone N., Fricker A.D., Stombaugh J., Knight R., Angenent L.T., Ley R.E. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. USA. 2011;108(Suppl. 1):4578-85.
  16. Stecher B., Hardt W.D. Mechanisms controlling pathogen colonization of the gut. Curr. Opin. Microbiol. 2011;14:82-91.
  17. Tourneur E., Chassin C. Neonatal immune adaptation of the gut and its role during infections. Clin. Dev. Immunol. 2013;270301.
  18. Oozeer R. Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides. Am. J. Clin. Nutr. 2013;98(2):561-71.
  19. Latuga M.S., Stuebe A., Seed P.C. A review of the source and function of microbiota in breast milk. Semin. Reprod. Med. 2014;32(1):68-73.
  20. Горелов А.В., Усенко Д.В. Роль микрофлоры желудочно-кишечного тракта и принципы коррекции нарушения ее состава. РМЖ. 2008;16(19):1.
  21. Барановский А.Ю. Кондрашина О.А. Дисбактериоз кишечника. М., 2008. 240 с.
  22. Ткаченко Е.И., Суворова А.Н. Дисбиоз кишечника. Руководство по диагностике и лечению. СПб., 2009. 278 с.
  23. Успенский Ю.П., Фоминых Ю.А. Антибиотик-ассоциированная диарея: актуальность проблемы, профилактика и терапия. Архив внутренней медицины. 2013;10(2):46-53.
  24. Buccigrossi V., Nicastro E., Guarino A. Functions of intestinal microflora in children. Curr. Opin. Gastroenterol. 2013;29(1 ):31 -8.
  25. Angelakis E., Million M., Kankoe S., Lagier J.C., Armougom F., Giorgi R., Raoult D. Abnormal weight gain and gut microbiota modifications are side effects of long-term doxycycline and hydroxychloroquine treatment. Antimicrob. Agents Chemother. 2014;58(6):3342-47.
  26. Bartlett J.G. Antibiotic-associated diarrhea. N. Engl. J. Med. 2001;346(5):334-39.
  27. Damrongmanee A., Ukarapol N. Incidence of Antibiotic Associated Diarrhea in a Pediatric Ambulatory Care Setting. J. Med. Assoc. Thai. 2007;90(3):513-17.
  28. Черников В.В., Сурков А.Н. Антибиотик-ассоциированная диарея у детей: принципы профилактики и лечения. Вопр. соврем. педиатрии. 2012;11(2):48-56.
  29. Захарова И.Н., Дмитриева Ю.А., Сугян Н.Г. Профилактика и лечение антибиотикассоциированных диарей у детей. Эксперим. и клин. гатсроэнтерология. 2011;1:88-92.
  30. Vaishnavi C. Clinical spectrum and pathogenesis of Clostridium difficile associated diseases. Indian. J. Med. Res. 2010;131:487-99.
  31. Парфенов А.И. Антибиотико-ассоциированный дисбиоз кишечника. Фарматека. 2013;6:87-9.
  32. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., McDonald L.C., Pepin J., Wilcox M.H. Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the society for health care epidemiology of America (SHEA) and the infectious diseases society of America(IDSA). Infect. Control. Hosp. Epidemiol. 2010;31:431-55.
  33. Сурков А.Н. Современные технологии в лечении и профилактике антибиотик-ассоциированной диареи у детей. Вопр. соврем. педиатрии. 2011;10(5):146-51.
  34. Johnston B.C., Ma S.S., Goldenberg J.Z., Thorlund K., Vandvik P.O., Loeb M., Guyatt G.H. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann. Intern. Med. 2012;157(12):878-88.
  35. Андреева И.В. Потенциальные возможности применения пробиотиков в клинической практике. Клин. микробиол. антимикроб. химиотер. 2006;8(2):151-72.
  36. EFFCA Guidelines for Probiotics in Food and Dietary Supplements. European Food and Feed Culture Association. 2008.
  37. Боровик Т.Э, Яцык С.П., Семенова Н.Н., Дюксеев И.А., Катосова Л.К., Кутафина Е.К., Шмакова С.Г. Эффективность применения синбиотика нормобакт в послеоперационном периоде у детей с хроническим обструктивным пиелонефритом. Эффективная фармакотерапия. Педиатрия. 2012;1:53-6.
  38. Алямовская Г.А. Нормобакт в коррекции нарушений микробиоценоза кишечника у детей раннего возраста. Практика педиатра. 2012;48-52.
  39. Рычкова Т.И., Зайцева О.В., Ефремова И.И., Стрига Е.В., Остроухова И.П., Чегодаева Н.А. Опыт применения синбиотика нормобакт в профилактике и лечении антибиотикоассоциированной диареи у детей с инфекцией мочевой системы. Педиатрия. 2011; 90(4):108-11.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies